Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-003491

President sold 30,000 shares at an average $61.93 ($1,857,960)

  • President acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-11 Exercise or conversion : show line 1 in the form +15,000 $6.32 $94,800 15,000 D
2021-01-11 Sale : show line 2 in the form −2,700 $59.62 $160,974 12,300 D
2021-01-11 Sale : show line 3 in the form −2,544 $60.68 $154,370 9,756 D
2021-01-11 Sale : show line 4 in the form −9,756 $61.74 $602,335 0 D
2021-01-12 Exercise or conversion : show line 5 in the form +15,000 $6.32 $94,800 15,000 D
2021-01-12 Sale : show line 6 in the form −9,872 $62.47 $616,704 5,128 D
2021-01-12 Sale : show line 7 in the form −5,128 $63.10 $323,577 0 D
Open-market sales · 30,000 sh · avg $61.93 · $1,857,960

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-01-11 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −15,000 290,000 D
2021-01-12 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −15,000 275,000 D
Loading xslF345X03/doc4.xml…